EUVIMEDEUVIMED entdecken
Crossref

Elucidation of Antidiabetic Mechanisms of β-Ocimene Through Network Pharmacology, Molecular Docking, and In-vitro Bioassays

Ankita Shukla, Abhishek Nagar

International Journal of Drug Delivery Technology · 08.06.2026 · 16 (48s)

DOI: 10.25258/ijddt.16.48s.96 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Drug Delivery Technology, online erschienen am 08.06.2026. Verfasst von Ankita Shukla und 1 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Type 1 diabetes mellitus (T1DM) is a chronic autoimmune disorder characterized by pancreatic β-cell destruction, insulin deficiency, and persistent hyperglycemia, leading to severe metabolic disturbances and long-term complications. β-Ocimene, a naturally occurring monoterpene with reported antioxidant and anti-inflammatory properties, was investigated in this study for its potential therapeutic role against T1DM using an integrated network pharmacology, molecular docking, and ADMET approach. A total of 7 β-Ocimene-associated targets were predicted using SwissTargetPrediction and Similarity Ensemble Approach databases. These targets were intersected with 20,775 T1DM-related genes retrieved from the GeneCards database, resulting in 7 common targets, including MAOB, ACHE, HTR2A, CXCR3, SHBG, CNR2, and PPARA. Protein–protein interaction analysis identified MAOB, ACHE, and HTR2A as key hub proteins involved in the pharmacological activity of β-Ocimene. Gene Ontology enrichment analysis revealed significant involvement in biological processes related to inflammatory response, regulation of apoptosis, ATP metabolic processes, glycolytic regulation, and response to oxygencontaining compounds. KEGG pathway analysis identified several relevant pathways, including serotonergic synapse, neuroactive ligand–receptor interaction, and amino acid metabolism pathways, suggesting a multi-target mechanism in T1DM pathogenesis. ADMET evaluation demonstrated favorable drug-like properties, including good gastrointestinal absorption (94.73%), acceptable lipophilicity, high oral bioavailability, blood–brain barrier permeability, and low predicted toxicity without mutagenic, hepatotoxic, or cardiotoxic effects. Molecular docking studies revealed stable interactions between β-Ocimene and multiple target proteins, with the strongest binding affinity observed for Cannabinoid receptor 2 (−6.3 kcal/mol), followed by Sex hormone-binding globulin (−6.2 kcal/mol), Acetylcholinesterase (−5.9 kcal/mol), and other hub proteins. These findings suggest that β-Ocimene may exert antidiabetic effects through modulation of oxidative stress, inflammation, neurotransmission, and metabolic signaling pathways, highlighting its potential as a promising natural therapeutic candidate for T1DM management.

Zitieren

APA

Shukla, A., & Nagar, A. (2026). Elucidation of Antidiabetic Mechanisms of β-Ocimene Through Network Pharmacology, Molecular Docking, and In-vitro Bioassays. International Journal of Drug Delivery Technology, 16(48s). https://doi.org/10.25258/ijddt.16.48s.96

Vancouver

Shukla A, Nagar A. Elucidation of Antidiabetic Mechanisms of β-Ocimene Through Network Pharmacology, Molecular Docking, and In-vitro Bioassays. International Journal of Drug Delivery Technology. 2026;16(48s). doi:10.25258/ijddt.16.48s.96

BibTeX
@article{Shukla2026,
  author = {Shukla, Ankita and Nagar, Abhishek},
  title = {Elucidation of Antidiabetic Mechanisms of β-Ocimene Through Network Pharmacology, Molecular Docking, and In-vitro Bioassays},
  journal = {International Journal of Drug Delivery Technology},
  year = {2026},
  volume = {16},
  number = {48s},
  doi = {10.25258/ijddt.16.48s.96}
}
Kostenlos starten →